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Abstract
In 1991, the costs for schizophrenia, which has a lifetime prevalence of 1.5% among adult 
Americans, totaled $65 billion. Costs were broken down into their direct and indirect components. 
Direct costs, which totaled $19 billion dollars, consisted of treatment-related expenditures such as 
those for inpatients and outpatients, as well as nontreatment-related expenditures such as those for 
the criminal justice system used by individuals with schizophrenia. The direct costs were fairly 
similar to those of other recent estimates of the cost of schizophrenia. Indirect costs, which were 
$46 billion dollars, included the lost productivity of both wage earners ($24 billion) and 
homemakers ($4.5 billion), individuals who were in institutions ($4.5 billion) or who had 
committed suicide ($7 billion), and caregivers who took care of schizophrenic family members 
($7 billion). Our method for calculating the indirect costs was slightly different than methods used 
in prior studies, which may account for our estimates being higher. The method for determining 
each expenditure is provided, and the implications of these staggering costs are discussed.
Introduction
Schizophrenia and schizophreniform disorders have a combined 1.5% lifetime prevalence 
among adult Americans [1]. In 1991, almost 3 million American adults between the ages of 
18 and 65 years were or would be schizophrenic sometime during their lives. These 
individuals require extensive services, and contribute to a dramatic loss of productivity. We 
estimate that, in 1991, schizophrenia cost the United States $19 billion in direct expenditures 
and $46 billion in lost productivity, a total of almost $65 billion.
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Direct and indirect costs—The aggregate economic cost of an illness is usually made up 
of two major components. The first of these is the direct consumption cost or direct cost, 
which consists of the actual dollar expenditures on medical care related to helping the 
patient function. Direct costs are the expenditures by federal, state, and local governments, 
private individuals, families and groups, and philanthropic organizations for current and 
future (research and training) care, prevention, and treatment. There are however, substantial 
direct costs that are not strictly treatment related. For example, many schizophrenic 
individuals are in jails and prisons; while we might hope that these institutions provide 
treatment, treatment is not these institutions’ primary function. In this analysis we have 
therefore broken the direct coats into treatment- and nontreatment-related direct costs 
(negative externalities). Economic losses, especially lost productivity due to illness, are 
known as indirect consumption costs or indirect costs and are the other component of the 
aggregate economic cost. Lost productivity implies “… not only that the individual fails to 
operate at his maximum capacity but that society could and would utilize him at his 
maximum if he could operate there” [2].
A major assumption involved in these calculations is that if direct expenditures were not 
being spent on ill individuals, the money would be used to make the nation more 
competitive in the market-place. A similar assumption is made about indirect costs, namely 
that if the patient could work, and if those who are providing uncompensated services to him 
could work for compensation, their efforts would go into making a marketable product. 
Consequently, this form of economic evaluation is viewed in relationship to the gross 
national product (GNP) or gross domestic product (GDP).
Inflation adjustments—When treatment-related direct costs were initially determined for 
a year other than 1991, they were adjusted to 1991 values by the Medical Care Consumer 
Price Index (CPI-U) [3]. Since nontreatment-related direct and indirect costs were more 
difficult to sort into their appropriate index components, the yearly CPI-U for all indexed 
items was used for these computations. The notation ADJ–CPI indicates that a cost underwent 
the appropriate CPI-U adjustment.
The population considered—The estimated 1991 costs included the 50 states, the 
District of Columbia, and United States territories. The territories contributed less than 2% 
of the total, but were included because they must be considered as part of the total national 
cost. It is likely that the direct costs did not include all costs for the territories, since a 
number of information sources, which often were not clear about the geographical scope 
upon which their estimates were based, probably did not include the territories. When data 
were obtained for a year other than 1991, the notation ADJ–POP indicates that an adjustment 
was made for population increases [4].
Use of the mean daily census—Inpatient and outpatient costs were generally 
determined using the mean daily censuses, rather than patient admission or discharge rates. 
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This made it unnecessary to determine the cost of patients experiencing multiple admissions, 
and avoided the problem of determining the average length of stay.
The Epidemiologic Catchment Area study and other sources of data
Data from current published sources were used when possible. Usually, these data needed to 
be updated. In those situations where estimates were required, information from informed 
individuals was acquired. It is a given that whether data came from published sources or had 
to be estimated, their trustworthiness is highly variable. When data were deemed to be less 
reliable, we used them in a way that we believe underestimated the true cost, thus providing 
a conservative estimate of the total cost of schizophrenia.
We relied heavily on the “first wave” of the National Institute of Mental Health (NIMH) 
Epidemiologic Catchment Area (ECA) survey for much of the data on prevalence and 
productivity [5]. This survey represents the largest study ever undertaken for the purposes of 
determining the amount and kinds of psychiatric illness extant in a population. It is also 
probably the best available survey of any medical disorder for the general population of the 
United States.
Use of 1-year versus lifetime prevalence—Normally, one would look at the cost of 
an illness during a year such as 1991 by counting only those individuals who had symptoms 
during that year. We held to this principle for direct treatment-related expenditures, but took 
a different approach for other expenditures. While for many illnesses it is likely that only 
those individuals with “active” symptoms would be actively treated, this is not necessarily 
true for chronic illnesses such as schizophrenia; treatments for schizophrenia are only 
capable of suppressing symptoms. It is likely that some individuals with well-controlled 
symptoms would not be counted as having active illnesses, although they would be included 
in the lifetime prevalence rates. In the ECA study, a diagnosis of active schizophrenia was 
made only if there were positive or productive symptoms such as hallucinations or 
delusions. These symptoms may not be present early or late in the course of schizophrenia, 
and some patients have symptoms such as hallucinations and delusions only rarely. The 
more incapacitating symptoms are more subtle (loss of drive, interest, and attention), but are 
very likely to reduce productivity. It is thus possible that an individual who reported no 
hallucinations or delusions during the last year, but had had them at one time would be 
classified as having schizophrenia in remission by the ECA study. Certainly, some of these 
individuals would be functioning normally. Others, however would be functioning poorly 
because of their residual symptoms.
Most of the productivity data used here came from the same survey as the prevalence data 
and has been expressed as lifetime prevalence. In our calculations, those individuals who 
had returned to normal lives did not contribute to the lost productivity for schizophrenia. 
Therefore, including them in the lifetime prevalence rate does not inflate the cost of 
schizophrenia. We similarly assumed that family care would be provided to individuals who 
would not have been considered actively ill during the last year according to the ECA study, 
since some of these individuals would have substantial residual symptoms. Finally, we also 
used lifetime prevalence rates for individuals in shelters, jails, and prisons.
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Assumption of normalcy—We assumed that a considerable amount of the estimated 
direct expenditure attributable to schizophrenia would have occurred whether or not the 
individuals were schizophrenic. For example, a certain percentage of those schizophrenic 
individuals in jails and prisons would be there regardless of whether or not they were 
schizophrenic. To allow for this assumption, the lifetime prevalence of schizophrenia in the 
general population (1.5%) was subtracted from the lifetime prevalence of schizophrenia in 
jails, prisons, and shelters. Not subtracting this figure would lead to an overestimate of the 
associated costs. The notation ADJ–NOR indicates that this adjustment was made. A similar 
adjustment was not made for crime and the criminal justice system because the baseline 
rates were derived only from those patients admitted to psychiatric hospitals. Individuals 
who were not hospitalized in the last year were not considered to have contributed to the 
crime expenditure.
Insurance administrative costs and overhead—Public institutions and third-party 
health payers such as Medicaid, Medicare, Blue Cross/Blue Shield, and other public and 
private health care organizations have administrative costs associated with processing 
claims, as well as collecting and distributing tax revenues and premiums. These 
administrative charges are made up through taxes, premiums, and donations. To account for 
these costs, we added 8.6% (the published administrative cost for Blue Cross/Blue Shield for 
1990 [6]) to all direct care expenditures except those provided by the Veterans 
Administration and the Department of Defense. These federal organizations are self-insured 
and have presumably calculated their administrative expenses into their published costs. The 
notation ADJ–INS indicates insurance overhead was added.
Capital costs—Several authors [2, 7] have argued that because there is no opportunity to 
use the publicly supported grounds and structures (where much of mental illness is treated) 
for commercial purposes, they represent a large hidden cost. As land values have increased 
and cities have spread into communities where large psychiatric hospitals have been for 
many years, there has been a substantial increase in the value of these properties. This is 
particularly true of the older psychiatric hospitals that tend to occupy large amounts of land. 
A recent study by Rosenheck et al. has estimated that the lost opportunity capital costs of the 
Veterans Administration hospitals were 6% of other operating expenses for inpatients, and 
4% for outpatients [8]. We used these values to estimate the lost opportunity capital costs of 
all governmental institutions (no value was given to lost opportunity capital cost for private 
faciIities, although one could argue that there should be such an estimate for not-for-profit 
institutions). For institutions where inpatient and outpatient costs were aggregated, we used 
the 6% value since most of the costs associated with such institutions are attributable to 
inpatient care. The notation ADJ–CAP indicates that the appropriate inpatient or outpatient 
capital costs were added.
Indirect cost issues
Prevalence- and incidence-based analysis—Direct costs and lost productivity are 
caIculated according to either prevalence- or incidence-based analysis. Prevalence-based 
analysis assigns the direct costs and lost productivity to the year in which they occur, with 
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the exception of lost productivity due to premature death, which is assigned entirely to the 
year of death. Incidence-based estimates assign all present and future direct costs and lost 
productivity to the year in which the costs began and therefore require the translation of 
future expenditures and lost productivity into current values, using the concept of discounted 
dollars. Another difference between prevalence- and incidence-based analyses is that 
prevalence-based methods look at all cases in which the disorder is present during the year, 
while incidence-based analysis examines only those individuals in whom the disease began 
that year.
Generally, prevalence-based analyses use aggregated figures, while incidence-based analysis 
requires a much more detailed knowledge of the component costs. While we primarily used 
a prevalence-based method, we attempted to break costs into as many components as the 
data allowed. We deviated somewhat from previous prevalence approaches by using 
averages or midpoints of populations whenever possible in order to make maximum use of 
the limited data available, as well as to facilitate computations.
A component of indirect costs that can make it difficult to compare one study with another is 
the degree to which secondary output losses are considered [9]. Legitimate components of 
indirect costs include the loss of productivity by others in a work force because they are 
coworkers of individuals with schizophrenia, the amount of time devoted by family 
members to caring for a schizophrenic, and time away from work of jurors who participate 
in the trial of an individual with schizophrenia. How far to extend these ripples of lost 
productivity is unclear. It seems reasonable to extend them to first-degree relatives who not 
only suffer a significant financial burden, but also have a substantial decrease in their quality 
of life. Further extension of this ripple effect, at least for schizophrenia, would probably add 
little to the total cost, although it is possible that for some disorders, particularly those where 
the entire cost is not so high, the extension of lost productivity to other workers in the 
workplace or other settings would make up a substantial percentage of the lost productivity. 
The only extension made beyond first-degree relatives was for victims of crime, since they 
were included in the available criminal data [4].
There are several forms of lost productivity associated with illness. The major divisions are 
between those individuals who work or would be expected to work for compensation if they 
were healthy, and those who would not be expected to work for compensation. The latter 
includes individuals who perform household work (homemakers), which has been estimated 
to account for 25–40% of the GNP [10]. Household workers, like those working for 
monetary compensation, can be producing at full or partial capacity, or not at all. Estimating 
the lost productivity for those who are working or would be expected to work if they were 
not ill requires knowing the average compensation (wages plus benefits) for working 
individuals. For an incidence-based estimate, where future earnings are discounted, it is 
necessary to project an increase in compensation over time since most individuals are 
compensated less when starting their careers than after those careers have been established. 
There is one other item that should probably go into estimates of lost productivity: profit. 
The compensation and profit attributed to an individual equal that individual’s total 
economic value to society, and together go into making up the nations’s GDP. However, 
since profit varies from year to year and would add an uncertain component to these 
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calculations, it was not estimated here, though it might be important when comparing costs 
across economic systems (i.e., capitalism versus socialism).
Since placing a value on household work is not as simple as calculating the lost productivity 
for compensated individuals, a number of methods have been developed to estimate the 
value of this work [9, 11]. To determine the value of household work that a schizophrenic 
individual would have been expected to perform but did not, we used the method of Peskin 
(1984) who used both the time men and women spent on specific household tasks and the 
wages that an individual performing those tasks would earn [12]. Similarly, we used the 
average 1991 wage to calculate the opportunities lost through family care. One might argue 
that we should have used compensation, but in this instance we relied heavily on the work of 
others who have used wages.
Results
A breakdown of actual and estimated costs of schizophrenia in 1991 is displayed in Table 1.
Direct costs
Treatment-related direct costs
Inpatient hospital care: Many of the data obtained from state and county mental hospitals, 
psychiatric services of nonfederal general hospitals, and multiservice hospitals do not 
separate inpatient from outpatient expenditures. In practical terms, the blurring of the costs 
associated with inpatient and outpatient treatment is more than simply an accounting issue, 
since patients often are not fully discharged when they leave the hospital. For example, there 
are many forms of partial hospitalization and extended leave. In our calculations, when there 
was no simple means of separating inpatient from outpatient expenditures, all expenditures 
were attributed to inpatient costs. This does not affect the total expenditures, but increases 
the inpatient expenditures at the expense of outpatient costs.
The average annual expenditure was calculated for private hospitals, state and county mental 
hospitals, Veterans Administration hospitals, nonfederal general hospitals, multiservice 
hospitals, the Department of Defense, and the Indian Health Service. The percentage of 
patients who were being treated for schizophrenia was assessed [13]. Insurance and capital 
costs were added to the total when applicable. Approximately one-third of the private 
hospitals allowed psychiatrists and other professionals to charge separately for their services 
[14]. The value of these services, calculated from the CHAMPUS (Civilian Health and 
Medical Program for Uniformed Service) data set, was added to the private hospital total 
[15].
Veterans Administration hospitals have expenditures in addition to that specifically targeted 
at psychiatric inpatient care, which include administrative, educational, and research costs. 
The figures obtained from the Department of Defense reflected the total mental health care 
costs of “direct health care”. All active duty servicemen (including those from the public 
health service), retirees, the dependents of both, and a small percentage of others (designees 
of the Department of Defense) are treated through direct care in hospitals run by the 
Department of Defense. Exceptions to this occur only if specific services are not available in 
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those hospitals (i.e., there is no heart surgeon), and in such a situation, CHAMPUS supplies 
the care (G. Willauer, personal communication, 1992).
The figures obtained from the Indian Health Service reflected only direct inpatient costs, 
since it was assumed that contract costs had been included elsewhere. These figures did not 
include the costs of alcohol and drug abuse (B. Douglas, personal communication, 1993).
The total inpatient expenditure for schizophrenia in 1991 was approximately $10,820 
millionADJ–CPI, INS, CAP.
Outpatient care: Most outpatient care expenditures were included under inpatient 
expenditures as discussed earlier. The average annual expenditure for free-standing 
outpatient clinics, Veterans Administration, the Department of Defense, Indian Health 
Service, and private care were calculated, and the percentage spent on schizophrenia for 
each was assessed. When applicable, insurance and capital costs were added to the total. 
Figures for Veterans Administration outpatient clinics included the share of administrative, 
research, and training expenditures attributable to schizophrenic outpatients in 1991.
This total also included expenditures for case management of individuals with 
schizophrenia. We were not able to separate case management from the other service costs 
provided by inpatient and outpatient facilities. Part of case management expenditures were 
therefore included in the estimate of inpatient and outpatient expenditures. For a number of 
years, however, many communities have provided case management services that are 
independent of traditional psychiatric services. In our efforts to obtain previously 
unestimated costs of case management for schizophrenia, we reviewed several studies 
[18-23] and conducted a number of interviews. Based upon interviews with several 
commissioners of state mental health systems, field workers, and scientists who are 
examining this issue, we learned that it is likely that attempts were made to provide some 
form of case management to most of the individuals with schizophrenia who had sought any 
form of psychiatric help in 1991. Again, based upon these interviews, we estimate that about 
50% of case management came from outside traditional mental health resources and had 
therefore not been counted in the estimated inpatient and outpatient service costs. We then 
contacted the supervisor of the Northern Virginia Outpatient Services, an organization that 
primarily serves individuals with chronic schizophrenia. She estimated that, in 1988, their 
workers spent 1.5 h with each chronic schizophrenic patient per week. It is unlikely, 
however, that most patients on a national level have weekly contact with a case manager, 
unless there is a crisis. The experts we interviewed felt that the average patient probably met 
with their case manager once a month.
In 1991, outpatient expenditures for schizophrenia totaled approximately $1,200 
millionADJ–CPI,POP,INS,CAP.
Nursing homes and intermediate and domiciliary care: The number of nursing home 
residents with schizophrenia was calculated and multiplied by the average yearly 
expenditure per patient. Insurance and capital costs were added. In addition to traditional 
inpatient and outpatient care, the Veterans Administration also operates intermediate care 
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beds and domiciliary care facilities [24]. The cost for the psychiatric part of these services 
was calculated (excluding pharmacy expenditures, nursing, or other overhead costs), and the 
percentage of that total used to treat individuals with schizophrenia was assessed. Capital 
costs were not added to domiciliary care since these patients receive care in their own home.
In 1991, the total nursing home and intermediate and domiciliary care and freestanding 
partial care center expenditure for schizophrenia was approximately $5,840 
millionADJ–CPI, INS, CAP.
Medication: The cost of most inpatient, other institutional, and some outpatient medications 
used to treat schizophrenia was included as part of the aggregate expenditures in the 
appropriate sections. In order to derive an expenditure that was not previously used, we 
assumed that the outpatient expenditure for medications was not previously included. A 
recent study of the adult, non-institutionalized population estimated that 485,491ADJ–POP 
individuals were taking antipsychotic medication in 1991 [25]. We assumed that all 
individuals taking antipsychotics were schizophrenic (cost associated with antipsychotics 
used to treat other disorders would be more than counterbalanced by the additional 
medications used by schizophrenic individuals whose costs were not included here). Based 
on this figure and on the annual cost of these medications we calculated that the cost of 
medications for individuals with schizophrenia in the community in 1991 was approximately 
$115 millionADJ–INS. The cost for medications represents the actual cost to the family 
devoid of any federal or insurance aid.
Treatment for drug and alcohol abuse: In our estimate, we used items that were not 
tabulated in previous sections of this study. Figures for specialty and federal institutions, 
office-based physicians, support costs, motor vehicle accidents, and social welfare 
administration, based on estimates from another study, were used [26]. In 1991, the total 
cost of treating substance abuse in individuals with schizophrenia was approximately $300 
millionADJ–CPI.
Supported living and shelters: Transitional living, such as half-way houses or bed and 
board housing, were partially accounted for in other categories, such as transfer costs. With 
the exception of shelters, we could not, however, provide a reasonable estimate for the rest 
of the cost associated with these living arrangements and, therefore, did not include them 
here. The cost of shelters, which provide a number of services not found in ordinary 
housing, has not previously been estimated. Surveys of shelter users are relatively consistent 
in their finding that a high percentage of individuals who use shelters have psychiatric 
disorders, and that a high percentage of those particular individuals have schizophrenia. We 
reviewed several studies [27-29], and determined that approximately 14.5%ADJ–NOR of 
shelter occupants are schizophrenic, although this is likely to be a conservative estimate. The 
cost of providing shelters for individuals with schizophrenia in 1991 was approximately 
$410 millionADJ–NOR, CPI.
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Non-treatment-related direct costs (negative externalities)
Law enforcement judicial system: There are many components to the costs of crime, 
including the cost of police and fire contact, pretrial investigations, property damage, lost 
victim productivity, as well as all adjudication, jury, and private defense costs. 
Unfortunately, data are limited on the amount of contact individuals with schizophrenia have 
with the police, the fire department, or the criminal justice system. We made the 
conservative assumption that only some of those schizophrenic individuals whose behavior 
was severe enough to be admitted to a hospital had such contact. This assumption was made, 
in part, because our most useful data associating schizophrenia with the crime rate came 
from a hospital admission study [30]. In 1991, there were 369,596 schizophrenic individuals 
admitted to psychiatric hospitals one or more times [5].
One cost originates from police contact with schizophrenic individuals following behavior 
disturbances (examples include public intoxication, loitering, disorderly conduct, and other 
misdemeanors) [31, 32]. In order to estimate the crime costs attributable to schizophrenic 
individuals, we used a study that surveyed 219 schizophrenic patients admitted to 
California’s Napa Valley State Hospital over a 19-month period [30]. Over the previous 8 
years, 55 of those patients had been arrested for violent or potentially violent crimes. Based 
on the number of crimes committed by the group described in this study, we developed a 
ratio of the total number of crimes committed by individuals with schizophrenia.
We assumed the expense for adjudicating violent and nonviolent crime attributable to 
schizophrenia was proportional to the cost for the general population. We also calculated the 
total cost of private legal services for the criminal defense attributable to individuals with 
schizophrenia [33], as well as the total victim loss attributable to admitted schizophrenic 
patients.
The lifetime prevalence of schizophrenia in jails is 4.4%ADJ–NOR [34]. We based our cost 
estimate on the average daily jail population [35] and on the cost of maintaining an inmate 
in that jail [36]. The lifetime prevalence of schizophrenia in prisons is 5.2%ADJ–NOR [36]. 
Other data used included the number of individuals in state and federal prisons [37] and the 
average cost of giving an inmate annual medical care [38]. The total expenditure for 
schizophrenic inmates in jails and prisons was $1,340 millionADJ–NOR,CAP.
In 1991, the total cost of crime due to schizophrenia, including jails and prisons, was 
approximately $2,000 million.
Suicide and suicide attempts: There is considerable excess mortality associated with 
schizophrenia and it is largely due to suicide [39, 40]. The expenditures associated with 
suicide and suicide attempts that stand out are the medical costs for attempted suicides, 
investigational costs for completed suicides, and lost productivity (covered in indirect costs).
Most reviews of the subject indicate that suicide attempts and suicide fire most common 
early in the course of the illness [39]. We assumed that approximately 33.4% of individuals 
with schizophrenia will make at least one suicide attempt [41], that individuals with 
schizophrenia only make one such attempt in their lives (this is undoubtedly an 
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underestimate), and that the one suicide attempt is serious (to some degree this assumption, 
which probably leads to an overestimate of the cost of suicide attempts, balances the 
underestimate of the number of attempts by a single individual). To estimate the number of 
suicide attempts per year, we assumed that they take place entirely during the first year of 
illness and calculated the number of suicide attempts from the mean age of onset and the 
lifetime prevalence of schizophrenia. Although costs of hospitalizations in psychiatric 
facilities were covered under inpatient psychiatric costs, serious suicide attempts require the 
use of ambulance services, emergency rooms, and inpatient medical services. It was 
assumed that all suicide attempts were from poisonings, an assumption that does not include 
those attempts that require costlier surgical procedures.
It was estimated that 8.2% of individuals with schizophrenia kill themselves and that the 
average age at suicide is 31 years [41]. The number of schizophrenic individuals who killed 
themselves in 1991 was 8,734ADJ–POP. Each completed suicide is associated with medical 
investigational costs. Interviews were conducted with law enforcement officials in the 
District of Columbia and Maryland to determine police expenditures for the investigation of 
a suicide, and the cost from the District of Columbia Medical Examiner’s office was also 
obtained.
In 1991 the total cost of suicide and suicide attempts was approximately $190 
millionADJ–CPI,POP.
Research and training: In 1991, the National Institute of Mental Health spent roughly $51 
million on direct grants for research and training in schizophrenia (C. Willabee, personal 
communication, 1992). States, private organizations, and pharmaceutical companies 
contributed about $20 million. In 1991, research and training costs for schizophrenia were 
approximately $71 million.
Adjustment for transfer costs: The normal consumption of goods and services is 
considered part of the total level of output of both the services and the goods of society, and 
is one of the benefits of society. Ideally, these societal benefits are present whether or not an 
individual is ill. A portion of the estimated direct expenditure attributable to schizophrenia, 
namely that for food, clothing, lodging, and basic medical expenses, is the minimal cost of 
living and would be incurred if the individuals were not schizophrenic. These are not costs 
of schizophrenia and should be subtracted from the total direct costs. To estimate these 
transfer costs, the poverty level for a one-person household under age 65 years was used. In 
1991, this was $6,331ADJ–CPI [43]. The number of schizophrenic individuals occupying 
hospital, nursing home, shelter, intermediate and domiciliary, prison, and jail beds had an 
associated transfer cost of approximately $2,320 millionADJ–CPI which was subtracted from 
the direct costs.
The total direct cost for schizophrenia in 1991, including all medical, substance abuse, 
shelters, criminal, suicide, research, and training costs, were approximately $18,600 million. 
This estimate includes an adjustment for transfer costs.
Wyatt et al. Page 10
























Gender: In the ECA study [5], there is a statistically nonsignificant trend for females to 
have a higher lifetime prevalence of schizophrenia than males. On the other hand, 
schizophrenia tends to be identified earlier in males, and males have a more severe course. 
Furthermore, when very strict criteria were used, males were reported to have a higher 
prevalence. Since males earn more than females, we took a conservative approach and 
assumed that the prevalence of schizophrenia for males and females is the same.
Skilled and non-skilled workers: The ECA study provides values for the earnings of both 
skilled and unskilled (farmers, operators, fabricators, laborers, and forestry personnel with 
the exception of managers) workers who have schizophrenia (L. Robins, personal 
communication, 1992). Average wages have been determined for each group [4].
Calculation of average compensation: The total compensation for all full-time workers has 
also been determined [43]. To calculate the average full-time total compensation for skilled 
and unskilled workers, the difference between cash and noncash incomes was obtained. In 
1991, the weighted average compensation (wages and salary payments to all full-time 
workers including executive bonuses, tips, payments-in-kind, employer contributions for 
social security insurance, director fees, private pensions, and welfare funds, etc.) for all full-
time workers, both skilled and unskilled, was $33,692ADJ–CPI. Lost productivity estimates 
assumed an individual would be productive from age 18 years to his or her 65th birthday, 
which is the common age of retirement.
Lost earnings of schizophrenic individuals
Paid and potentially paid individuals with schizophrenia: To calculate lost 
compensation, it was necessary to use lifetime prevalence rates, since data on the percentage 
of individuals with schizophrenia who were working are provided in this form [5]. 
Compared with 56.3% of the general adult population who were employed, only 42.8% of 
individuals with schizophrenia were currently employed [5]. Furthermore, compared with 
the general population, individuals with schizophrenia were overrepresented in unskilled 
jobs by 20% and underrepresented in skilled jobs by 60%, meaning that they were partially 
disabled. We determined the combined lost productivity for individuals with schizophrenia, 
including those who were not working (and would have been working had they not been ill) 
and those who were working but were partially disabled.
Unpaid work, nonmonetary production, or homemaking: As with the paid or potentially 
paid schizophrenic individuals, there were two forms of lost productivity; the first assumed 
total disability and the second, partial disability. It was assumed that the percentage of 
individuals with schizophrenia who were both homemakers and nonproductive equaled the 
percentage of individuals with schizophrenia who were totally disabled potential wage 
earners.
Lost productivity from those in institutions: In 1991, there were 192, 820ADJ–POP 
individuals with schizophrenia between the ages of 18 and 65 years in psychiatric 
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institutions, shelters, nursing homes, jails, and prisons. During their stay at the institution, 
the individuals occupying those beds could be considered to be nonproductive. Since the 
estimates of lost productivity are based on household samples and, therefore, fail to take the 
institutionalized population into account, their totals were added.
Premature mortality, suicide: The conventional way of estimating the lost productivity of 
those individuals who killed themselves would be to project the earnings for the rest of their 
lives and discount them into 1991 dollars. Discounting inflates the cost for the current year 
by bringing future earnings into it. There are at least two alternatives that consider the 
effects of past deaths on current productivity: the “cohort method” and the “steady-state 
method.” The cohort method examines what would have happened to productivity had the 
individual not died. It adjusts for both changing populations and the increased earnings of 
individuals who were not old enough to have reached their maximal earning at the time of 
their death. The steady-state method, which we used because of its simplicity, assumes that 
the same number of people die each year from an illness. The lost productivity therefore 
depends on the number of years an individual would be expected to be productive, the 
average age of retirement, and the number of people who die during that year. This method, 
while simple, overestimates the loss by using the number of individuals dying in the present 
year, which, in a growing society, will be higher than the number who died in the past. At 
the same time, it underestimates the lost productivity by failing to consider that healthy 
individuals would be paid greater salaries later in life.
Lost family productivity: Family caregivers are largely, but not exclusively, parents who 
are taking care of their schizophrenic child. These parents may have wished to reenter the 
work force after their children had grown, or they may have returned to school and 
improved their position in the work force. Similarly, many who receive wages must take 
time away from work to care for their family member and therefore are less well 
compensated than they would have been otherwise. Since we only considered schizophrenic 
individuals aged 18 years and over in our cost of schizophrenia estimates, it is our 
assumption that the family who takes care of an ill family member is doing so rather than 
working for compensation, Therefore, we used the 1991 weighted mean of the average 
compensation of a wage earner and a homemaker to calculate the opportunities lost through 
family care.
The estimate of time lost to family caregiving is based on a 1985 survey of members of the 
National Alliance of the Mentally Ill (NAMI), which ascertained how many hours of care 
families provide to their schizophrenic family member [45] (cited in [7]), Sixty-five 
thousand families belong to NAMI, and 64% of these families have one or more 
schizophrenic members [46]. However, only a small percentage of families with a 
schizophrenic member belong to NAMI. Since there is little basis for determining the 
amount of time the average non-NAMI family spends with their schizophrenic family 
member, a conservative estimate was made that they average one-third the amount of time 
spent by the average NAMI family. Use of this conservative value also takes into 
consideration that some individuals with schizophrenia have no family working on their 
behalf, and that, in 1991, not all individuals with a lifetime diagnosis of schizophrenia 
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needed family help. Furthermore, those individuals with schizophrenia living in institutions 
were not included in this estimate. Also, while lifetime prevalence rates are likely to 
increase the number of individuals needing help in 1991, individuals who had the symptoms 
of schizophrenia prior to age 18 (including those who became schizophrenic as children) 
were not included in this estimate. In the initial Franks study, most of the time contributed 
by family members was for caregiving, but some time was also attributed to recreation and 
other activities [7]. Since the identified schizophrenic in the survey was almost always an 
“adult child,” it seems reasonable to assume that the vast majority of this time would not 
have been spent had the individual not been schizophrenic.
The total indirect costs, including lost wages, decreased work performance of compensated 
workers and homemakers, family caregiving, suicide, and the lost productivity of those 
individuals in institutions was approximately $46,520 million in 1991.
In 1991, then, the total cost of schizophrenia was $65,180 million
Discussion
It should come as no surprise that schizophrenia is a very expensive illness. We believe that 
the estimated expenditures are conservative, although they are higher than other recent 
estimates. As more information becomes available, and more elements of the costs are 
identified, the cost of schizophrenia will probably be found to be even greater than the 
estimate presented here.
Many issues will come to mind when looking at these costs. One issue that requires 
consideration is the overlap between the costs associated with schizophrenia and other 
illnesses, especially since these estimates are for individuals with schizophrenia and 
schizophreniform illness. It is not unusual to consider both schizophrenia and 
schizophreniform illness as each being comprised of more than a single disease. For 
example, some individuals given the diagnosis of schizophreniform disorder may ultimately 
be diagnosed as having a bipolar disorder. To the degree that this is true, the cost of 
schizophrenia will be inflated at the expense of bipolar and other psychotic disorders. 
However, mis-identified individuals in the estimate of the cost of bipolar disorder, which 
follows this paper and which uses the same data base, will not be counted twice. If the costs 
of one illness are higher at the expense of the other, the total cost of the two disorders 
together should not be compromised.
The same problem could be encountered if the costs of substance abuse and schizophrenia 
were added without considering that they may consist of overlapping expenditures. In 
essence, the sum of the parts would be more expensive than the whole. Because of the 
nature of schizophrenia, we argue that most individuals with schizophrenia abuse drugs and 
alcohol due to their schizophrenia and that the costs should therefore be attributed to 
schizophrenia rather than to substance abuse. Nevertheless, any attempt at adding the cost of 
the two problems should subtract the overlapping costs from one or the other side.
For those who see this staggering cost and want to know how to reduce it, we point out that 
the ratio of non-treatment-related to treatment-related direct costs is about 12%. The major 
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portion of non-treatment-related direct costs stem from schizophrenic individuals interacting 
with the law enforcement/judicial system. The indirect costs, however, which make up 71% 
of the total, are where the real burden lies. This high cost only crudely reflects the 
devastation that this illness causes for millions of individuals.
The numbers presented are intended to be meaningful when compared with the GDP. The 
lost productivity and capital costs, however, are “would-have-beens.” The lost productivity 
or lost opportunity costs assume a loss to the GDP. However, were these losses added to the 
real GDP, one would have to assume a slightly greater GDP than exists.
We compared our figures with those of other studies. In a 1975 study, Gunderson and 
Mosher estimated that schizophrenia cost the United States an adjusted total of $40 
billionADJ–CPI for 1991 [47]. Using an incidence-based approach and Australian data, one 
study has estimated that schizophrenia cost the United States an adjusted total of $19 
billionADJ-CPI in 1991 [48].
Recently, Rice and Miller have estimated that for 1991, the cost of schizophrenia was $34 
billionADJ-CPI [49]. Since much of our analysis is derived from methods developed by Rice 
and her colleagues, a comparison of the results should help explain some of the differences 
in our estimates. Even though much of the data for the two studies was derived from 
different sources, and our study included a number of elements not found in the one 
conducted by Rice and Miller, the estimated direct costs of the two were surprisingly 
similar. Our study subtracted the basic cost of living for all institutionalized individuals 
(transfer costs), included capital costs, and included the population of United States 
territories. Still, our direct costs were $18.6 billion and Rice and Miller’s were $19.5 
billionADJ–CPI.
The major difference in our studies was in the treatment of three specific indirect costs: 
suicide, compensation of workers, and family caregiving. When determining an estimate for 
the cost of suicide, we assumed a greater number of premature deaths than did Rice, which 
contributed to our higher cost. There is also a substantial difference in the way we estimated 
lost earnings. Rice and Miller discounted future earnings in order to bring them into today’s 
dollars. We, on the other hand, assumed that individuals who killed themselves in the past 
would have remained productive until their 65th birthday had they not killed themselves, 
and therefore did not discount what they would have earned.
Rice and Miller used a timing model for the lost productivity of compensated workers that 
attempted to match the lost earnings by age, gender, and impairment. We calculated lost 
earnings by first determining an average compensation for all full-time employees and then 
adjusting for degree of disability. We believe, however, that we used similar estimates of 
lost earnings for homemakers.
To estimate the cost of family caregiving we went beyond the lost compensation for NAMI 
members and presented estimates for non-NAMI members as well. For NAMI members we 
used the fult estimate from the Franks survey and 33% of that figure for all other families, 
minus those with family members in institutions [45]. Rice and Miller used 33% of the 
Franks figure for all families. The major difference lies in the fact that we estimated that 
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there were more individuals with schizophrenia living in the community than did Rice and 
Miller. We suspect that their method underestimates a large group of individuals who 
require considerable family assistance. These differences in the calculation of indirect costs 
are significant enough to account for the discrepancy between our two estimates.
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Table 1
Costs of schizophrenia-rounded totals in millions
Direct costs
Treatment-related: Total inpatient costs $10,820 million
Total outpatient costs $1,200 million




Medication SI 15 million
Substance abuse $300 million
Shelters $410 million








Transfer costs – $2,320 million





Lost productivity, institutions $4,500 million
Lost productivity, suicide S7,000 million
Lost family, productivity $7,000 million
Lost compensation $23,600 million
Total indirect costs $46,500 million
1991 Total (direct and
indirect)
$65,200 million
Soc Psychiatry Psychiatr Epidemiol. Author manuscript; available in PMC 2015 January 21.
